BioTheryX Inc, a biotechnology company focused on treating difficult diseases, has raised $35 million in Series D financing. MSD Partners LP led the round. Raymond James’ Alex Brown division was the placement agent for the financing.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: